The treatment of hypertension in women

Norman M Kaplan

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

More women than men eventually develop hypertension, but they suffer less cardiovascular damage as a consequence. Primary hypertension in women has a greater volume component, often related to commonly associated obesity. Most lifestyle modifications have more to offer women, but women respond in a similar manner to various antihypertensive drugs. However, women appear to receive less benefit from antihypertensive therapy, as measured by morbidity and mortality data in multiple large clinical trials. Women who take oral contraceptives typically have a small rise in blood pressure, and in a small percentage, the rise is sufficient to induce hypertension. The prevalence is likely lower with currently used low-dose estrogen formulations. The use of estrogen for postmenopausal replacement therapy almost never raises the blood pressure, so that concerns about hypertension should not interfere with the use of this valuable therapy.

Original languageEnglish (US)
Pages (from-to)563-567
Number of pages5
JournalArchives of Internal Medicine
Volume155
Issue number6
StatePublished - 1995

Fingerprint

Hypertension
Antihypertensive Agents
Therapeutics
Blood Pressure
Estrogen Replacement Therapy
Oral Contraceptives
Life Style
Estrogens
Obesity
Clinical Trials
Morbidity
Mortality

ASJC Scopus subject areas

  • Internal Medicine

Cite this

The treatment of hypertension in women. / Kaplan, Norman M.

In: Archives of Internal Medicine, Vol. 155, No. 6, 1995, p. 563-567.

Research output: Contribution to journalArticle

Kaplan, NM 1995, 'The treatment of hypertension in women', Archives of Internal Medicine, vol. 155, no. 6, pp. 563-567.
Kaplan, Norman M. / The treatment of hypertension in women. In: Archives of Internal Medicine. 1995 ; Vol. 155, No. 6. pp. 563-567.
@article{35eaffdf28f1418a889acac40ac5c094,
title = "The treatment of hypertension in women",
abstract = "More women than men eventually develop hypertension, but they suffer less cardiovascular damage as a consequence. Primary hypertension in women has a greater volume component, often related to commonly associated obesity. Most lifestyle modifications have more to offer women, but women respond in a similar manner to various antihypertensive drugs. However, women appear to receive less benefit from antihypertensive therapy, as measured by morbidity and mortality data in multiple large clinical trials. Women who take oral contraceptives typically have a small rise in blood pressure, and in a small percentage, the rise is sufficient to induce hypertension. The prevalence is likely lower with currently used low-dose estrogen formulations. The use of estrogen for postmenopausal replacement therapy almost never raises the blood pressure, so that concerns about hypertension should not interfere with the use of this valuable therapy.",
author = "Kaplan, {Norman M}",
year = "1995",
language = "English (US)",
volume = "155",
pages = "563--567",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - The treatment of hypertension in women

AU - Kaplan, Norman M

PY - 1995

Y1 - 1995

N2 - More women than men eventually develop hypertension, but they suffer less cardiovascular damage as a consequence. Primary hypertension in women has a greater volume component, often related to commonly associated obesity. Most lifestyle modifications have more to offer women, but women respond in a similar manner to various antihypertensive drugs. However, women appear to receive less benefit from antihypertensive therapy, as measured by morbidity and mortality data in multiple large clinical trials. Women who take oral contraceptives typically have a small rise in blood pressure, and in a small percentage, the rise is sufficient to induce hypertension. The prevalence is likely lower with currently used low-dose estrogen formulations. The use of estrogen for postmenopausal replacement therapy almost never raises the blood pressure, so that concerns about hypertension should not interfere with the use of this valuable therapy.

AB - More women than men eventually develop hypertension, but they suffer less cardiovascular damage as a consequence. Primary hypertension in women has a greater volume component, often related to commonly associated obesity. Most lifestyle modifications have more to offer women, but women respond in a similar manner to various antihypertensive drugs. However, women appear to receive less benefit from antihypertensive therapy, as measured by morbidity and mortality data in multiple large clinical trials. Women who take oral contraceptives typically have a small rise in blood pressure, and in a small percentage, the rise is sufficient to induce hypertension. The prevalence is likely lower with currently used low-dose estrogen formulations. The use of estrogen for postmenopausal replacement therapy almost never raises the blood pressure, so that concerns about hypertension should not interfere with the use of this valuable therapy.

UR - http://www.scopus.com/inward/record.url?scp=0028962359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028962359&partnerID=8YFLogxK

M3 - Article

C2 - 7887751

AN - SCOPUS:0028962359

VL - 155

SP - 563

EP - 567

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 6

ER -